miR-aculous new avenues for cancer immunotherapy

The rising toll of cancer globally necessitates ingenuity in early detection and therapy. In the last decade, the utilization of immune signatures and immune-based therapies has made significant progress in the clinic; however, clinical standards leave many current and future patients without option...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, William W., Bauer, Kaylyn M., Barba, Cindy, Ekiz, Huseyin Atakan, O’Connell, Ryan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554277/
https://www.ncbi.nlm.nih.gov/pubmed/36248881
http://dx.doi.org/10.3389/fimmu.2022.929677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554277/
https://www.ncbi.nlm.nih.gov/pubmed/36248881
http://dx.doi.org/10.3389/fimmu.2022.929677

Ejemplares similares